Trabecular and cortical bone loss in systemic lupus erythematosus

British Journal of Rheumatology

Volumn 35, Issue 3, 1996, Pages 244-247

  Houssiau, F A ^a,b   Lefebvre, C ^a   Depresseux, G ^a   Lambert, M ^a   Devogelaer, J P ^a   Nagant de Deuxchaisnes, C ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Bone; Densitometry; Glucocorticoids; Systemic lupus erythematosus

Indexed keywords

GLUCOCORTICOID;

ABSORPTIOMETRY; ADULT; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE MINERAL; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICAL BONE; FEMALE; FRACTURE; HIP; HUMAN; LUMBAR SPINE; PRIORITY JOURNAL; RISK; SYSTEMIC LUPUS ERYTHEMATOSUS; TRABECULAR BONE;

EID: 0029996401     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/35.3.244     Document Type: Article

References (14)

1. Reveille JD, Bartolucci A, Alarcon GS. Prognosis in systemic lupus erythematosus. Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death. Arthritis Rheum 1990;33:37-48.
2. Devogelaer JP, Nagant de Deuxchaisnes C. Therapy in the 1990s. Osteoporosis. Br J Rheumatol 1993;32(suppl. 4):48-55.
3. Dhillon VB, Davies MC, Hall ML et al Assessment of the effect of oral glucocorticoids on bone mineral density in systemic lupus erythematosus: a preliminary study with dual energy x ray absorptiometry. Ann Rheum Dis 1990;49:624-6.
4. Khalla AA, Fataar AB, Jessop SJ, Bewerunge L. Loss of trabecular bone mineral density in systemic lupus erythematosus. Arthritis Rheum 1993;36:1726-34.
5. Formiga F, Moga I, Nolla JM, Pac M, Mitjavila F, Roig-Escofet D. Loss of bone mineral density in pre- menopausal women with systemic lupus erythematosus. Ann Rheum Dis 1995;54:274-6.
6. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-5.
7. Devogelaer JP, Le Thi C, Depresseux G, Nagant de Deuxchaisnes C. Reproducibility of bone mass measurements in human volunteers using three DPA and one dual-energy X-ray bone densitometers: correlation between instruments. In: Ring EFG, ed. Current research in osteoporosis and bone mineral measurements. London: British Institute of Radiology, 1987:36.
8. Devogelaer JP, Nagant de Deuxchaisnes C. Reproducibility of body composition values on QDR-1000/W. Calcif Tissue Int 1993;52:163.
9. Steiger P, Devogelaer JP, Ettinger B, Marcus R, Stein JA. Precision in vivo and accuracy of morphometric X-ray absorptiometry. Bone 1995;16(suppl. 1):149S.
10. Cummings SR, Black DM, Nevitt MC et al. Bone densities at various sites for the prediction of hip fractures. Lancet 1993;341:72-5.
11. Melton LJ, Atkinson EJ, O'Fallon WM, Wahner HW, Riggs BL. Long-term fracture prediction by bone mineral assessed at different skeletal sites. J Bone Min Res 1993;8:1227-33.
12. Reid IR. Pathogenesis and treatment of steroid osteoporosis. Clin Endocrinol 1989;30:83-103.
13. Nagant de Deuxchaisnes C, Devogelaer JP, Esselinckx W et al. The effect of low dosage glucocorticoids on bone mass in rheumatoid arthritis: a cross-sectional and a longitudinal study using single photon absorptiometry. Adv Exp Med Biol 1984;171:209-39.
14. Linker-Israeli M, Deans RJ, Wallace DJ, Prehn J, Ozeri-Chen T, Klinenberg JR. Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. J Immunol 1991;147:117-23.